Pre-incarceration polysubstance use involving opioids: A unique risk factor of postrelease return to substance use.
Criminal justice
Opioids
Polysubstance use
Prison
Reentry
Journal
Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
03
09
2020
revised:
07
12
2020
accepted:
02
03
2021
entrez:
17
6
2021
pubmed:
18
6
2021
medline:
6
8
2021
Statut:
ppublish
Résumé
Justice-involved populations are at increased risk of overdose following release from prison and jail. This risk is exacerbated by polysubstance use, including the use of opioids with other substances. This study explored pre-incarceration polysubstance use involving opioids as a unique risk factor for postrelease return to substance use. The study examined data from a cohort of 501 justice-involved persons who were enrolled in a therapeutic community treatment program while incarcerated. Latent profile validation identified profiles of polysubstance use involving opioids prior to incarceration. Multivariate logistic regression examined return to substance use, defined as self-reported relapse, and a time series model examined time in the community until a relapse event occurred. A latent profile validation found six unique polysubstance opioid patterns prior to incarceration. Two of these profiles, primarily alcohol and primarily buprenorphine, were at increased and accelerated risk for relapse postrelease relative to a less polysubstance use profile. Both profiles at increased risk had pre-incarceration co-use of marijuana (≈45% of month) and nonmedical use of opioids (≈40% of month) but were unique in their respective near daily use of alcohol and nonmedical buprenorphine. Among persons who use opioids returning to the community, return to substance use occurs along a continuum of risk. Providers' consideration of polysubstance use patterns during treatment may assist in mitigating adverse outcomes for patients postrelease.
Identifiants
pubmed: 34134861
pii: S0740-5472(21)00080-5
doi: 10.1016/j.jsat.2021.108354
pmc: PMC8217721
mid: NIHMS1680797
pii:
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
108354Subventions
Organisme : NIDA NIH HHS
ID : K02 DA035116
Pays : United States
Organisme : NIDA NIH HHS
ID : R25 DA037190
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA035200
Pays : United States
Organisme : AHRQ HHS
ID : T32 HS026120
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Références
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
J Abnorm Psychol. 2003 May;112(2):219-27
pubmed: 12784831
Drug Alcohol Depend. 2015 Aug 1;153:43-9
pubmed: 26105708
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Public Health Rep. 1994 Sep-Oct;109(5):665-72
pubmed: 7938388
NIDA Res Monogr. 1986;72:185-90
pubmed: 3099207
Addict Sci Clin Pract. 2018 Dec 3;13(1):23
pubmed: 30509314
Subst Use Misuse. 2020;55(13):2165-2174
pubmed: 32686551
J Subst Abuse Treat. 1992;9(3):199-213
pubmed: 1334156
J Subst Abuse Treat. 2017 Mar;74:16-22
pubmed: 28132695
J Addict. 2016;2016:7620860
pubmed: 27722007
BMC Psychiatry. 2012 Aug 15;12:111
pubmed: 22894706
Vital Health Stat 2. 2014 Apr;(166):1-73
pubmed: 24776070
Drug Alcohol Depend. 1995 Oct;39(3):231-5
pubmed: 8556972
Addict Sci Clin Pract. 2015 Jan 16;10:2
pubmed: 25592182
Int J Prison Health. 2013;9(4):169-86
pubmed: 25083160
Clin Psychol Rev. 2007 Jul;27(6):724-38
pubmed: 17355897
JAMA. 2018 May 1;319(17):1819-1821
pubmed: 29715347
J Addict Nurs. 2019 Jul/Sep;30(3):219-223
pubmed: 31478970
Curr Drug Abuse Rev. 2011 Mar;4(1):28-41
pubmed: 21466501
Drug Alcohol Depend. 2009 May 1;101(3):152-7
pubmed: 19181458
N Engl J Med. 2007 Jan 11;356(2):157-65
pubmed: 17215533
MMWR Morb Mortal Wkly Rep. 2020 Sep 04;69(35):1189-1197
pubmed: 32881854
Clin Psychol Rev. 2006 Mar;26(2):162-78
pubmed: 16406196
Am Psychol. 2004 May-Jun;59(4):224-35
pubmed: 15149263
J Subst Abuse Treat. 2007 Oct;33(3):229-41
pubmed: 17889295
Compr Psychiatry. 2003 Jul-Aug;44(4):293-302
pubmed: 12923707
Addict Sci Clin Pract. 2019 Feb 19;14(1):7
pubmed: 30782211
Addiction. 2016 Jul;111(7):1214-23
pubmed: 26857811
SSM Popul Health. 2017 Jan 31;3:219-226
pubmed: 29349219
Harm Reduct J. 2010 Oct 15;7:24
pubmed: 20950455
Am J Public Health. 2020 Feb;110(2):244-250
pubmed: 31855487
Eval Rev. 2007 Dec;31(6):515-47
pubmed: 17986706
Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S35-8
pubmed: 16769443
AIDS. 2005 Oct;19 Suppl 3:S26-33
pubmed: 16251824
Am J Public Health. 2001 Nov;91(11):1842-6
pubmed: 11684613
J Addict Med. 2011 Sep;5(3):175-80
pubmed: 21844833
Addict Sci Clin Pract. 2012;7:3
pubmed: 22966409
Addiction. 1996 Dec;91 Suppl:S15-27
pubmed: 8997778
J Med Virol. 2003 Jul;70(3):387-90
pubmed: 12767001
J Epidemiol Community Health. 2008 Apr;62(4):305-13
pubmed: 18339822
J Subst Abuse Treat. 2008 Jul;35(1):78-86
pubmed: 17931826
AIDS Behav. 2013 Oct;17 Suppl 2:S171-80
pubmed: 23142854
Psychol Addict Behav. 2000 Dec;14(4):390-6
pubmed: 11130157
Addiction. 2015 Jun;110(6):1008-14
pubmed: 25703440
Addict Behav. 2010 Aug;35(8):741-9
pubmed: 20444552
Eur Addict Res. 2007;13(4):207-15
pubmed: 17851242
Crim Justice Behav. 2008;35(1):34-47
pubmed: 18612373
PLoS One. 2011;6(11):e27244
pubmed: 22087270
Psychol Addict Behav. 2008 Jun;22(2):157-67
pubmed: 18540713
Ann Intern Med. 2013 Nov 5;159(9):592-600
pubmed: 24189594